Cargando…
Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome
Cardiopoietic stem cells have reached advanced clinical testing for ischemic heart failure. To profile their molecular influence on recipient hearts, systems proteomics was here applied in a chronic model of infarction randomized with and without human cardiopoietic stem cell treatment. Multidimensi...
Autores principales: | Arrell, D. Kent, Rosenow, Christian S., Yamada, Satsuki, Behfar, Atta, Terzic, Andre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067830/ https://www.ncbi.nlm.nih.gov/pubmed/32194990 http://dx.doi.org/10.1038/s41536-020-0091-6 |
Ejemplares similares
-
Secretome signature of cardiopoietic cells echoed in rescued infarcted heart proteome
por: Arrell, D. Kent, et al.
Publicado: (2021) -
Cardiopoietic programming of embryonic stem cells for tumor-free heart repair
por: Behfar, Atta, et al.
Publicado: (2007) -
Ventricular remodeling in ischemic heart failure stratifies responders to stem cell therapy
por: Yamada, Satsuki, et al.
Publicado: (2019) -
Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design
por: Bartunek, Jozef, et al.
Publicado: (2015) -
Cardiopoietic stem cell therapy in ischaemic heart failure: long‐term clinical outcomes
por: Bartunek, Jozef, et al.
Publicado: (2020)